Drug
Polypepi1018
Polypepi1018: highest development phase Phase 2, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| PolyPEPI1018 NCT05243862 | Phase 2 | Colorectal Cancer Metastatic |
Latest
No recent events.
Follow Polypepi1018 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.